Schedule 13D Amendment No. 1

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13D

(Amendment No. 1)*

Under the Securities Exchange Act of 1934

 

 

SRI/Surgical Express, Inc.

(Name of Issuer)

 

 

Common Stock, par value $.001 per share

(Title of Class of Securities)

78464W104

(CUSIP Number)

John W. Kauffman, Esquire

Duane Morris LLP

30 South 17th Street

Philadelphia, PA 19103; telephone: 215-979-1227

(Name, Address, and Telephone Number of Person Authorized to Receive Notices and Communications)

April 2, 2012

(Date of Event Which Requires Filing of this Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f), or 240.13d-1(g), check the following box.  ¨

Note: Schedules filed in paper format shall include a signed original and five copies of the Schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Exchange Act”) or otherwise subject to the liabilities of that section of the Exchange Act but shall be subject to all other provisions of the Exchange Act (however, see the Notes).

 

 

 

 

1

SCHEDULE 13D

 

CUSIP No. 78464W104  

 

  1   

NAME OF REPORTING PERSON/I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities only)

 

Henry Partners, L.P.

I.R.S. I.D. No. 23-2888396

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  x        (b)  ¨

 

  3  

SEC USE ONLY

 

  4  

SOURCE OF FUNDS (See Instructions)

 

    WC

  5  

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

 

    N/A

  6  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

    Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

      7    

SOLE VOTING POWER

 

    *

     8   

SHARED VOTING POWER

 

    *

     9   

SOLE DISPOSITIVE POWER

 

    *

   10   

SHARED DISPOSITIVE POWER

 

    *

11

  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

    *

12

  

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)    ¨

 

13

  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

    *

14

  

TYPE OF REPORTING PERSON (See Instructions)

 

    PN

 

* NOTE: Reporting Persons own less than 5% of the Issuer’s outstanding common stock.

 

2

CUSIP No. 78464W104  

 

  1   

NAME OF REPORTING PERSON/I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities only)

 

Matthew Partners, L.P.

I.R.S. I.D. No. 23-3063303

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  x        (b)  ¨

 

  3  

SEC USE ONLY

 

  4  

SOURCE OF FUNDS (See Instructions)

 

    WC

  5  

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

 

    N/A

  6  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

    Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

      7    

SOLE VOTING POWER

 

    *

     8   

SHARED VOTING POWER

 

    *

     9   

SOLE DISPOSITIVE POWER

 

    *

   10   

SHARED DISPOSITIVE POWER

 

    *

11

  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

    *

12

  

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)    ¨

 

13

  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

    *

14

  

TYPE OF REPORTING PERSON (See Instructions)

 

    PN

 

* NOTE: Reporting Persons own less than 5% of the Issuer’s outstanding common stock.

 

3

CUSIP No. 78464W104  

 

  1   

NAME OF REPORTING PERSON/I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities only)

 

Henry Investment Trust, L.P.

I.R.S. I.D. No. 23-2887157

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  x        (b)  ¨

 

  3  

SEC USE ONLY

 

  4  

SOURCE OF FUNDS (See Instructions)

 

    WC

  5  

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

 

    N/A

  6  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

    Pennsylvania

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

      7    

SOLE VOTING POWER

 

    *

     8   

SHARED VOTING POWER

 

    *

     9   

SOLE DISPOSITIVE POWER

 

    *

   10   

SHARED DISPOSITIVE POWER

 

    *

11

  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

    340,300 shares

12

  

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)    ¨

 

13

  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

    *

14

  

TYPE OF REPORTING PERSON (See Instructions)

 

    PN

 

* NOTE: Reporting Persons own less than 5% of the Issuer’s outstanding common stock.

 

4

CUSIP No. 78464W104  

 

  1   

NAME OF REPORTING PERSON/I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities only)

 

David W. Wright

  2  

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

(a)  x        (b)  ¨

 

  3  

SEC USE ONLY

 

  4  

SOURCE OF FUNDS (See Instructions)

 

    WC

  5  

CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)

 

    N/A

  6  

CITIZENSHIP OR PLACE OF ORGANIZATION

 

    United States of America

NUMBER OF

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING

PERSON

WITH

      7    

SOLE VOTING POWER

 

    *

     8   

SHARED VOTING POWER

 

    *

     9   

SOLE DISPOSITIVE POWER

 

    *

   10   

SHARED DISPOSITIVE POWER

 

    *

11

  

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

    *

12

  

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions)    ¨

 

13

  

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

 

    *

14

  

TYPE OF REPORTING PERSON (See Instructions)

 

    IN

 

* NOTE: Reporting Persons own less than 5% of the Issuer’s outstanding common stock.

 

5

Item 1. Security and Issuer.

This statement relates to shares of the common stock, $.001 par value per share, of SRI/Surgical Express, Inc. (the “Issuer”). The principal executive offices of the Issuer are located at 12425 Race Track Road, Tampa, Florida 33626.

 

Item 5. Interest in Securities of the Issuer.

The Reporting Persons ceased to be beneficial owners of more than 5% of the outstanding shares of the Issuer’s common stock on April 2, 2012.

 

6

SIGNATURE

After reasonable inquiry and to the best of the undersigneds’ knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

 

       

HENRY PARTNERS, L.P., by its General

Partner, HENRY INVESTMENT TRUST, L.P.,

by its General Partner, CANINE PARTNERS, LLC

Date: April 5, 2012     By:  

/s/ David W. Wright

      David W. Wright,
      President
   

MATTHEW PARTNERS, L.P., by its General

Partner, HENRY INVESTMENT TRUST, L.P.,

by its General Partner, CANINE PARTNERS, LLC

Date: April 5, 2012     By:  

/s/ David W. Wright

      David W. Wright,
      President
   

HENRY INVESTMENT TRUST, L.P., by its

General Partner, CANINE PARTNERS, LLC

Date: April 5, 2012     By:  

/s/ David W. Wright

      David W. Wright,
      President
Date: April 5, 2012      

/s/ David W. Wright

      David W. Wright

 

7